SBRT improved local progression-free survival over RFA in small recurrent HCC, particularly in tumors 2 cm or less.

Patients receiving SBRT received 27.5 to 50 Gy in 5 fractions. The primary endpoint of this study was OS; secondary endpoints included PFS, adverse events, and quality of life.

Adding stereotactic body radiotherapy to enzalutamide and ADT for oligometastatic castration-resistant prostate cancer prolongs radiographic progression-free survival. Adding metastasis-directed ...

The UAB Department of Radiation Oncology has partnered with Varian to develop a three-day conference that discusses and demonstrates stereotactic radiation (SRS) and stereotactic body radiation (SBRT) ...

Stereotactic body radiation therapy, also known as stereotactic ablative radiotherapy has emerged as a treatment modality that allows the precise delivery of a large ablative radiation dose to a ...

Tumor ablation, and ablative radiation therapies such as stereotactic body radiation therapy (SBRT), are mainstays of minimally invasive solid cancer treatment that use physical means such as heat ...